T Schulze1, A Bembenek, P M Schlag. 1. Klinik für Chirurgie und Klinische Onkologie, Charité, Campus Buch, Robert-Rössle-Klinik im HELIOS Klinikum Berlin, Lindenberger Weg 80, 13125, Berlin, Germany.
Abstract
BACKGROUND: Forty-three years after the first description of the sentinel lymph node technique in malignant tumours of the parotid by Gould, sentinel lymph node biopsy (SNLB) has become a precious tool in the treatment of solid tumours. METHODS: In the following review we give a synopsis of the fundamentals of the sentinel lymph node concept and then proceed to an overview of recent advances of SNLB in gastrointestinal cancers. RESULTS: In some tumour entities, SNLB has been shown to reflect reliably the lymph node status of the tumour-draining lymph node basin. In melanoma and breast cancer, it became a widely accepted element of the routine surgical management of these malignant diseases. In gastrointestinal tumours, the technique is currently under intense investigation. First reports on its application in other solid tumours, such as non-small cell lung cancer, thyroid carcinoma, oropharyngeal carcinoma, vulvar carcinoma, and Merckel cell carcinoma of the skin, were published more recently. CONCLUSION: SNLB has become an important component of diagnosis and treatment of solid tumours. A growing number of publications on SNLB in gastrointestinal cancer documents the interest of many investigators in the application of this technique in this tumour entity. As long as imaging techniques like 18FDG PET or other molecular imaging techniques are limited by their spatial resolution, SNLB remains the technique of choice for lympho-nodal staging.
BACKGROUND: Forty-three years after the first description of the sentinel lymph node technique in malignant tumours of the parotid by Gould, sentinel lymph node biopsy (SNLB) has become a precious tool in the treatment of solid tumours. METHODS: In the following review we give a synopsis of the fundamentals of the sentinel lymph node concept and then proceed to an overview of recent advances of SNLB in gastrointestinal cancers. RESULTS: In some tumour entities, SNLB has been shown to reflect reliably the lymph node status of the tumour-draining lymph node basin. In melanoma and breast cancer, it became a widely accepted element of the routine surgical management of these malignant diseases. In gastrointestinal tumours, the technique is currently under intense investigation. First reports on its application in other solid tumours, such as non-small cell lung cancer, thyroid carcinoma, oropharyngeal carcinoma, vulvar carcinoma, and Merckel cell carcinoma of the skin, were published more recently. CONCLUSION: SNLB has become an important component of diagnosis and treatment of solid tumours. A growing number of publications on SNLB in gastrointestinal cancer documents the interest of many investigators in the application of this technique in this tumour entity. As long as imaging techniques like 18FDG PET or other molecular imaging techniques are limited by their spatial resolution, SNLB remains the technique of choice for lympho-nodal staging.
Authors: L A Newman; K K Hunt; T Buchholz; H M Kuerer; G Vlastos; N Mirza; F C Ames; M I Ross; S E Singletary Journal: Am J Surg Date: 2000-10 Impact factor: 2.565
Authors: J J Bonenkamp; J Hermans; M Sasako; C J van de Velde; K Welvaart; I Songun; S Meyer; J T Plukker; P Van Elk; H Obertop; D J Gouma; J J van Lanschot; C W Taat; P W de Graaf; M F von Meyenfeldt; H Tilanus Journal: N Engl J Med Date: 1999-03-25 Impact factor: 91.245
Authors: K S Nason; B O Anderson; D R Byrd; L K Dunnwald; J F Eary; D A Mankoff; R Livingston; R A Schmidt; K D Jewell; R S Yeung; R E Moe Journal: Cancer Date: 2000-12-01 Impact factor: 6.860
Authors: A Fernández; M Cortés; E Benito; D Azpeitia; L Prieto; A Moreno; Y Ricart; J Mora; A Escobedo; J Martín Comín Journal: Nucl Med Commun Date: 2001-04 Impact factor: 1.690
Authors: J E Gershenwald; M I Colome; J E Lee; P F Mansfield; C Tseng; J J Lee; C M Balch; M I Ross Journal: J Clin Oncol Date: 1998-06 Impact factor: 44.544
Authors: Johan S Rietman; Pieter U Dijkstra; Jan H B Geertzen; Peter Baas; Jaap De Vries; Wil Dolsma; Johan W Groothoff; Willem H Eisma; Harald J Hoekstra Journal: Cancer Date: 2003-08-15 Impact factor: 6.860
Authors: P B A A van Driel; M van de Giessen; M C Boonstra; T J A Snoeks; S Keereweer; S Oliveira; C J H van de Velde; B P F Lelieveldt; A L Vahrmeijer; C W G M Löwik; J Dijkstra Journal: Mol Imaging Biol Date: 2015-06 Impact factor: 3.488
Authors: Rick G Pleijhuis; Maurits Graafland; Jakob de Vries; Joost Bart; Johannes S de Jong; Gooitzen M van Dam Journal: Ann Surg Oncol Date: 2009-07-17 Impact factor: 5.344